ロード中...

Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia

The current treatment for pediatric acute lymphoblastic leukemia (ALL) is highly successful with high cure rate. However, the treatment of adult ALL remains a challenge, particularly for refractory and/or relapsed (R/R) ALL. The advent of new targeted agents, blinatumomab, inotuzumab ozogamycin, and...

詳細記述

保存先:
書誌詳細
出版年:J Hematol Oncol
主要な著者: Zhao, Juanjuan, Song, Yongping, Liu, Delong
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6376657/
https://ncbi.nlm.nih.gov/pubmed/30764841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0705-x
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!